Financial reports
10-K
2023 FY
Annual report
28 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
10 Aug 22
10-Q
2022 Q1
Quarterly report
11 May 22
10-K
2021 FY
Annual report
31 Mar 22
10-Q
2021 Q3
Quarterly report
15 Nov 21
Current reports
8-K
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results
28 Mar 24
8-K
Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System
11 Mar 24
8-K
Other Events
14 Feb 24
8-K
Regulation FD Disclosure
9 Jan 24
8-K
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX® nsPFA™ Cardiac Clamp
2 Jan 24
8-K
Submission of Matters to a Vote of Security Holders
22 Dec 23
8-K
Pulse Biosciences Announces First-in-Human Procedures with its Novel CellFX™ Nanosecond Pulsed Field Ablation (nsPFA™) Cardiac Catheter
20 Dec 23
8-K
Regulation FD Disclosure
27 Nov 23
8-K
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode
21 Nov 23
8-K
Pulse Biosciences Reports Business Updates and Third Quarter 2023 Financial Results
13 Nov 23
Registration and prospectus
S-3/A
Shelf registration (amended)
23 Apr 24
S-3/A
Shelf registration (amended)
15 Apr 24
S-3
Shelf registration
3 Apr 24
S-3
Shelf registration
28 Mar 24
S-3
Shelf registration
11 Aug 23
S-8
Registration of securities for employees
10 May 23
424B3
Prospectus supplement
19 May 22
S-8
Registration of securities for employees
13 May 22
424B5
Prospectus supplement for primary offering
4 May 22
S-3
Shelf registration
3 Sep 21
Proxies
DEFA14A
Additional proxy soliciting materials
23 Apr 24
DEF 14A
Definitive proxy
23 Apr 24
DEF 14A
Definitive proxy
27 Nov 23
PRE 14A
Preliminary proxy
13 Nov 23
DEFA14A
Additional proxy soliciting materials
14 Apr 23
DEF 14A
Definitive proxy
14 Apr 23
DEFA14A
Additional proxy soliciting materials
1 Apr 22
DEF 14A
Definitive proxy
1 Apr 22
DEF 14A
Definitive proxy
14 Apr 21
DEF 14A
Definitive proxy
14 Apr 20
Other
EFFECT
Notice of effectiveness
9 Apr 24
EFFECT
Notice of effectiveness
31 Aug 23
CORRESP
Correspondence with SEC
29 Aug 23
UPLOAD
Letter from SEC
18 Aug 23
SD
Conflict minerals disclosure
31 May 23
UPLOAD
Letter from SEC
15 Aug 22
CORRESP
Correspondence with SEC
14 Jul 22
UPLOAD
Letter from SEC
30 Jun 22
CORRESP
Correspondence with SEC
9 Jun 22
SD
Conflict minerals disclosure
31 May 22